Johnson David Michael
SEC CIK 1808098 · EDGAR
BoughtSold
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:09 | 2026-06-16 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +57.1K | 307.5K | +23% | $0 | |
| D | 2026-06-15 16:30 | 2026-06-11 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +15.0K | 194.2K | +8% | $0 |
| 2025-06-18 | 2025-06-17 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +57.6K | 250.4K | +30% | $0 | |
| D | 2025-06-18 | 2025-06-17 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +13.0K | 179.2K | +8% | $0 |
| D | 2025-05-20 | 2025-05-16 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $4.90 | +20.0K | 166.2K | +14% | +$98.0K |
| D | 2024-06-24 | 2024-06-20 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +10.5K | 146.2K | +8% | $0 |
| 2024-06-21 | 2024-06-21 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +48.4K | 192.8K | +34% | $0 | |
| 2023-11-13 | 2023-11-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | P - Purchase | $9.88 | +17.0K | 144.4K | +13% | +$168.0K | |
| MI | 2023-11-09 | 2023-11-07+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $7.19 | +114.0K | 75.0K | New | +$820.0K |
| M | 2023-11-09 | 2023-11-07+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $7.18 | +85.6K | 126.1K | +212% | +$615.0K |
| M | 2023-10-05 | 2023-10-03+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $8.38 | +20.1K | 50.1K | +67% | +$168.2K |
| 2023-06-16 | 2023-06-16 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +19.1K | 127.4K | +18% | $0 | |
| MI | 2023-01-09 | 2023-01-05+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $10.41 | +2,000 | 17.1K | +13% | +$20.8K |
| MI | 2022-12-30 | 2022-12-28 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $9.75 | +4,000 | 17.0K | +31% | +$39.0K |
| MI | 2022-12-15 | 2022-12-01 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $12.37 | +10.0K | 15.0K | +200% | +$123.7K |
| MI | 2022-06-14 | 2022-06-10+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $14.30 | +20.0K | 10.0K | New | +$286.1K |
| M | 2022-06-14 | 2022-06-10+ | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | P - Purchase | $14.34 | +30.0K | 30.0K | New | +$430.2K |
| 2022-06-10 | 2022-06-08 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +24.9K | 108.3K | +30% | $0 | |
| DA | 2021-12-17 | 2021-06-04 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | A - Grant | $0.00 | +7,500 | 96.4K | +8% | $0 |
| DI | 2021-11-02 | 2021-11-02 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Dir | C - Cnv Deriv | $0.00 | +139.7K | 139.7K | New | $0 |
| M | 2021-10-04 | 2021-10-04 | ZNTL | Zentalis Pharmaceuticals, Inc. | Johnson David Michael | Dir | S - Sale | $66.35 | -12.9K | 89.0K | -13% | -$855.6K |
Purchase Sale Sale after option exercise All abbreviations